Variable gene expression within human tyrosinemia type 1 liver may reflect region-specific dysplasia

Hepatology

Volumn 24, Issue 1, 1996, Pages 65-71

  Haber, Barbara A ^a,b   Chuang, Emil ^a   Lee, Wendi ^a   Taub, Rebecca ^b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; GLUCOSE 6 PHOSPHATASE; SOMATOMEDIN BINDING PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; DYSPLASIA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER DISEASE; NORTHERN BLOTTING; PRIORITY JOURNAL; TISSUE SPECIFICITY; TYROSINEMIA;

EID: 0029971037     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1996.v24.pm0008707285     Document Type: Article

References (29)

1. Goldsmith LA, Laberge C. Tyrosinemia and related disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D, ed. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:547-562.
2. Linblad B, Lindstedt S, Steen G. On the enzymatic defects in hereditary tyrosinemia. Proc Natl Acad Sci U S A 1977;74:4641-4645.
3. Grompe M, Al-Dhalimy M. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia type I. Hum Mutat 1993; 2:85-93.
4. Grompe M, St. Louis M, Devers SI, Al-Dhalimy M, Leclerc B, Tanquay RM. A single mutation of the fumarylacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I. N Engl J Med 1994;331: 353-357.
5. LaBelle Y, Phaneuf D, Leclerc B, Tanguay RM. Characterization of the human fumarylacetoacetate hydrolase gene and identification of a missense mutation abolishing enzymatic activity. Hum Mol Genet 1993;2: 941-946.
6. Paradis S, Mitchell G, Russo P. Tyrosinemia. In: Suchy AJ, ed. Liver disease in children. Philadelphia: Mosby, 1994:803-818.
7. Dehner LP, Snover DC, Sharp HL, Ascher N, Nakhleh R, Day DL. Hereditary tyrosinemia type I (chronic form): pathologic findings in the liver. Hum Pathol 1989;20:149-158.
8. Ruppert S, Kelsey G, Schedl A, Schmid E, Thies E, Schutz G. Deficiency of an enzyme of tyrosine metabolism underlies altered gene expression in newborn liver of lethal albino mice. Genes Dev 1992;6:1430-1443.
9. Ruppert S, Boshart M, Bosch FX, Schmid W, Fournier REK, Schutz G. Two genetically defined trans-acting loci coordinately regulate overlapping sets of liver-specific genes. Cell 1990;61:895-904.
10. Haber BA, Mohn KL, Diamond RH, Taub R. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J Clin Invest 1993;91:1319-1326.
11. Haber BA, Chin S, Chuang E, Buikhuisen W, Naji A, Taub R. High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest 1995;95:832-841.
12. Haber BA, Naji L, Cressman D, Taub R. Coexpression of liver-specific and growth-induced genes in perinatal and regenerating liver: attainment and maintenance of the differentiated state during rapid proliferation. HEPATOLOGY 1995;22:906-914.
13. Lindstedt S, Holme E, Lock EA, Hjalmarson O, Strandvik B. Treatment of hereditary tyrosinemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase. Lancet 1992;340:813-817.
14. Jamieson NV. Improved preservation of the liver for transplantation [Review]. Aliment Pharmacol Ther 1991;5:91-104.
15. Davis L, Dibner M, Battey J. Basic methods in molecular biology. New York: Elsevier, 1986:
16. Mohn KL, Laz TM, Hsu J-C, Melby AE, Bravo R, Taub R. The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate early genes. Mol Cell Biol 1991;11:381-390.
17. Lee J, Greenbaum L, Haber BA, Nagle D, Lee V, Miles V, Mohn KL, et al. Structure and localization of the IGFBP-1 gene and its expression during liver regeneration. HEPATOLOGY 1994;19:656-665.
18. Sheehan DC, Hrapchak BB. Theory and practice of histotechnology. St. Louis: Mosby, 1980:143.
19. Lefkowitch JH. Pathology of the liver. Current Opinion in Gastroenterology 1992;3:409-417.
20. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1291.
21. Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. In situ hybridization studies on expression of albumin and alpha-fetoprotein during the early stage of neoplastic transformation in rat liver. Cancer Res 1987;47:5469-5475.
22. Schirmacher P, Held WA, Yang D, Chisari FV, Rustum Y, Rogler CE. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. Cancer Res 1995; 52:2549-2556.
23. Rogler CE, Chisari FV. Cellular and molecular mechanisms of hepatocarcinogenesis. Semin Liver Dis 1992;12:265-278.
24. Yang D, Alt E, Rogler CE. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered foci in woodchuck hepatitis virus carriers. Cancer Res 1993;53:2020-2027.
25. Rogler CE, Yang D, Rossetti L, Donohoe J, Alt E, Chang CJ, Rosenfeld R, et al. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor II transgenic mice. J Biol Chem 1994; 269:13779-13784.
26. Mohn KL, Melby AE, Tewari DS, Laz TM, Taub R. The gene encoding rat insulin-like growth factor-binding protein 1 is rapidly and highly induced in regenerating liver. Mol Cell Biol 1991;11:1393-1401.
27. Jirtle RL, Carr BI, Scott CD. Modulation of insulin-like growth factor-II/ mannose 6-phosphate receptors and transforming growth facto r-beta 1 during liver regeneration. J Biol Chem 1991;266:22444-22450.
28. McCusker RH, Busby WH, Dehoff MH, Camacho-Hubner C, Clemons DR. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins. Endocrinology 1991;129: 939-949.
29. Cohen P, Lamson G, Okajima T, Rosenfeld RG. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993;7:380-386.